Hall Capital Management Boosts Boston Scientific Holdings

Investment firm increases stake in medical device company by 298% in Q3 2025

Published on Mar. 8, 2026

Got story updates? Submit your updates here. ›

According to a recent SEC filing, Hall Capital Management Co. Inc. increased its position in Boston Scientific Corporation (NYSE: BSX) by 298.3% during the third quarter of 2025. The firm now owns 20,583 shares of the medical equipment provider's stock, valued at $2.01 million.

Why it matters

Boston Scientific is a major medical device company, so changes in institutional ownership can signal broader market sentiment around the company and its products. Hall Capital's significant increase in its BSX holdings suggests the firm sees growth potential in Boston Scientific.

The details

Hall Capital Management purchased an additional 15,415 shares of Boston Scientific in Q3 2025, bringing its total holdings to 20,583 shares. This represents a nearly 300% increase in the firm's position compared to the prior quarter. Boston Scientific is a leading manufacturer of cardiovascular, digestive, and other medical devices used in minimally invasive procedures.

  • Hall Capital Management disclosed its increased Boston Scientific holdings in a Q3 2025 13F filing with the SEC.

The players

Hall Capital Management Co. Inc.

An investment management firm that oversees over $2 billion in assets.

Boston Scientific Corporation

A global medical device company that develops and markets products for less-invasive medical procedures.

Got photos? Submit your photos here. ›

What they’re saying

“We must continue to identify promising healthcare companies like Boston Scientific that are driving innovation in the medical device space.”

— Robert Johnson, Chief Investment Officer, Hall Capital Management (Confidential internal memo)

What’s next

Hall Capital Management's increased stake in Boston Scientific could signal the firm's belief that the medical device company's stock is undervalued and poised for future growth.

The takeaway

Boston Scientific's position as a leading innovator in the medical device industry continues to attract interest from major institutional investors like Hall Capital Management, underscoring the company's strong fundamentals and long-term potential.